Literature DB >> 15223264

Tributyltin-sulfhydryl interaction as a cause of immunotoxicity in phagocytes of tunicates.

Francesca Cima1, Loriano Ballarin.   

Abstract

We reported elsewhere that tributyltin (TBT) has detrimental effects on the immune system of the colonial ascidian Botryllus schlosseri, through interaction with calmodulin and alteration of Ca2+ homeostasis. Here, we studied the capability of TBT to react with intracellular thiols. After exposure to 0.1 microM TBT, a significant decrease in B. schlosseri hemocytes stained for total thiols and reduced glutathione (GSH) was detected. Exogenous sulfhydryl and sulfide compounds can prevent TBT-induced cell morphology alterations and decrease the percentage of tin-containing hemocytes, indicating the scavenging ability of thiol peptides. No effects were observed with disulfides, N-acetylcysteine, or the GSH fragment Cys-Gly. No interactions were observed with TBT and carmustine, whereas TBT and N-ethylmaleimide (NEM) showed a combined antagonistic action, suggesting direct interaction of TBT with thiol-containing compounds. Regulation of Ca2+ efflux from internal stores seems to depend on stimulation of the inositol 1,4,5-trisphosphate (InsP3) receptor by oxidized glutathione (GSSG), which results from interactions of both TBT-GSH and TBT-GSH reductase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223264     DOI: 10.1016/j.ecoenv.2003.07.011

Source DB:  PubMed          Journal:  Ecotoxicol Environ Saf        ISSN: 0147-6513            Impact factor:   6.291


  2 in total

1.  Glutathione diminishes tributyltin- and dibutyltin-induced loss of lytic function in human natural killer cells.

Authors:  Jeralyn J Powell; McLisa V Davis; Margaret M Whalen
Journal:  Drug Chem Toxicol       Date:  2009       Impact factor: 3.356

2.  Triphenyltin Chloride Delays Leydig Cell Maturation During Puberty in Rats.

Authors:  Linchao Li; Lubin Xie; Leikai Ma; Yong Chen; Xianwu Chen; Fei Ge; Tongliang Huang; Lanlan Chen; Tingting Hong; Xiaofang Chen; Qiqi Zhu; Xingwang Li; Ren-Shan Ge
Journal:  Front Pharmacol       Date:  2018-08-10       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.